In particular, the TP53-related signature enclosing genes predominantly involved in cell cycle, DNA repair, signal transduction and apoptosis was predictive of poor prognosis in ER-positive/HER2-negative breast cancer (Table 2). This evidence concerns the gene ERBB2 and breast cancer.